Robert E. Ward
2017 - Sevion Therapeutics
In 2017, Robert E. Ward earned a total compensation of $8.7M as Chief Executive Officer at Sevion Therapeutics.
Compensation breakdown
| Option Awards | $3,428,806 |
|---|---|
| Stock Awards | $5,305,696 |
| Total | $8,734,502 |
Ward received $5.3M in stock awards, accounting for 61% of the total pay in 2017.
Ward also received $3.4M in option awards.
Rankings
In 2017, Robert E. Ward's compensation ranked 811th out of 14,666 executives tracked by ExecPay. In other words, Ward earned more than 94.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 811 out of 14,666 | 95th |
Division Manufacturing | 271 out of 5,772 | 95th |
Major group Chemicals And Allied Products | 67 out of 2,075 | 97th |
Industry group Drugs | 47 out of 1,731 | 97th |
Industry Biological Products, Except Diagnostic Substances | 8 out of 313 | 97th |
Source: SEC filing on April 16, 2018.
Ward's colleagues
We found three more compensation records of executives who worked with Robert E. Ward at Sevion Therapeutics in 2017.